NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,425.10 -0.80 (-0.03%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,937.64 +183.33 (+0.33%)
MRNA May 2024 117.000 call
| Previous close | 16.25 |
| Open | 16.25 |
| Bid | 22.95 |
| Ask | 30.35 |
| Strike | 117.00 |
| Expiry date | 2024-05-24 |
| Day's range | 16.25 - 16.25 |
| Contract range | N/A |
| Volume | |
| Open interest | 32 |
ZacksSanofi (SNY) Signs Deal for AI-Powered Drug Development
Sanofi (SNY) inks collaboration deal with Formation Bio and OpenAI to build AI-powered software to advance drug development and create new medicines.
BenzingaChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings. Sanofi said the partnership with OpenAI will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional engineering resources. The three teams will combine data, software, and tuned models t
Simply Wall St.Selling US$3.3m Of Moderna Stock Rewarded Insiders
Moderna, Inc.'s (NASDAQ:MRNA) stock rose 12% last week, but insiders who sold US$3.3m worth of stock over the last year...
